NTRA
Natera Inc
366.30$
+6.1%
vs. previous close
Closing price · As of: Sep 17, 2026
Ownership
Ownership Structure
Who owns Natera Inc (NTRA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 97.1% of the shares are freely tradable; institutional investors hold 95.8%.
Institutional ownership
?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
95.8%
Insiders
?Share of the stock held by the executives, founders and major shareholders of the company itself.
3.0%
Float
?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
97.1%
Short % of float
?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
3.9%
Shares Outstanding
?Total number of shares issued. Price times share count gives market cap.
144Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| JPMorgan Chase & Co | 9.29 | 13,386,667 | +4.1 | 03/31/2026 |
| T. Rowe Price Associates, Inc. | 8.45 | 12,184,876 | +12.1 | 03/31/2026 |
| BlackRock Inc | 7.41 | 10,677,338 | -1.7 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.17 | 6,008,496 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 3.92 | 5,644,695 | +0.0 | 03/31/2026 |
| Wellington Management Company LLP | 2.80 | 4,040,738 | -15.3 | 06/30/2026 |
| State Street Corp | 2.37 | 3,417,472 | +5.9 | 03/31/2026 |
| Farallon Capital Management, L.L.C. | 2.23 | 3,207,366 | -18.1 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| JPMorgan Large Cap Growth I | 3.85 | 5,550,940 | +0.0 | 07/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.01 | 4,333,872 | +0.3 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | 2,125,394 | 778,531,822 $ | Sep 15, 2026 | both |
| Sheena Jonathan | Director | 266,528 | 97,629,206 $ | Jul 15, 2026 | both |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | 197,257 | 72,255,239 $ | Aug 10, 2026 | direct |
| Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | 170,073 | 62,297,740 $ | Aug 3, 2026 | direct |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 110,859 | 40,607,652 $ | Sep 2, 2026 | direct |
| Chapman Steven Leonard | CEO AND PRESIDENT | 98,199 | 35,970,294 $ | Sep 1, 2026 | direct |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 51,637 | 18,914,633 $ | Aug 4, 2026 | direct |
| Chapman Rowan E | Director | 4,663 | 1,708,057 $ | Jul 15, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2,000 | 350.01 | 700,014 |
| Sep 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 800 | 351.25 | 280,996 |
| Sep 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 14,500 | 350.81 | 5,086,700 |
| Sep 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 4,206 | 349.51 | 1,470,038 |
| Sep 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 8,094 | 348.65 | 2,821,945 |
| Sep 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,122 | 346.68 | 388,969 |
| Sep 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2,700 | 347.81 | 939,094 |
| Sep 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 5,839 | 344.49 | 2,011,453 |
| Sep 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2,240 | 343.56 | 769,583 |
| Sep 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,956 | 342.18 | 669,305 |
| Sep 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,813 | 341.41 | 618,970 |
| Sep 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2,549 | 340.25 | 867,293 |
| Sep 15, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,481 | 339.24 | 502,407 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 4,064 | 342.51 | 1,391,947 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2,700 | 341.35 | 921,636 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2,000 | 340.31 | 680,626 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2,100 | 339.37 | 712,673 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,400 | 338.30 | 473,614 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2,207 | 337.17 | 744,132 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 8,459 | 336.27 | 2,844,474 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 3,754 | 335.18 | 1,258,268 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2,818 | 334.24 | 941,878 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2,246 | 333.07 | 748,065 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,000 | 332.02 | 332,017 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 3,494 | 330.98 | 1,156,427 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 6,206 | 330.05 | 2,048,299 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 6,015 | 329.12 | 1,979,639 |
| Sep 14, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,537 | 328.09 | 504,281 |
| Sep 11, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 1,300 | 329.62 | 428,512 |
| Sep 11, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 15,764 | 328.95 | 5,185,571 |
| Sep 11, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 17,933 | 327.97 | 5,881,529 |
| Sep 11, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 10,556 | 327.14 | 3,453,334 |
| Sep 11, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 3,647 | 326.11 | 1,189,315 |
| Sep 11, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 800 | 325.01 | 260,006 |
| Sep 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 15,160 | 326.89 | 4,955,713 |
| Sep 1, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 600 | 321.91 | 193,144 |
| Sep 1, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 1,400 | 320.92 | 449,292 |
| Sep 1, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 1,000 | 319.76 | 319,758 |
| Sep 1, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 1,698 | 320.99 | 545,041 |
| Aug 10, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 6,517 | 321.53 | 2,095,411 |
| Aug 10, 2026 | Sheena Jonathan | Director | Sell | 6,000 | 325.32 | 1,951,942 |
| Aug 7, 2026 | Sheena Jonathan | Director | Sell | 489 | 320.90 | 156,920 |
| Aug 7, 2026 | Sheena Jonathan | Director | Sell | 200 | 317.97 | 63,593 |
| Aug 7, 2026 | Sheena Jonathan | Director | Sell | 5,111 | 316.61 | 1,618,203 |
| Aug 7, 2026 | Sheena Jonathan | Director | Sell | 600 | 315.32 | 189,191 |
| Aug 7, 2026 | Sheena Jonathan | Director | Sell | 850 | 314.25 | 267,114 |
| Aug 7, 2026 | Sheena Jonathan | Director | Sell | 900 | 313.07 | 281,760 |
| Aug 7, 2026 | Sheena Jonathan | Director | Sell | 400 | 311.88 | 124,752 |
| Aug 7, 2026 | Sheena Jonathan | Director | Sell | 100 | 318.63 | 31,863 |
| Aug 7, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 2,000 | 320.90 | 641,800 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.